Quick Links

 Jeffrey N. Weitzel, M.D.

  • Chief, Clinical Cancer Genetics
  • Associate Professor, Medical Oncology & Therapeutics Research
  • Associate Professor, Medical Oncology & Therapeutics Research, Molecular Medicine
  • Director, Cancer Screening & Prevention Program Network
  • Director, Cancer Genetics Education Program
  • Full Member, Cancer Control and Population Sciences Program, Comprehensive Cancer Center

Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr.Weitzel's multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased risk for developing cancer because of family cancer history or personal risk factors.

Professional Experience

2004 - present, Associate Professor of Oncology, City of Hope; and Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA

1997 - present, Clinical Associate Professor of Preventive Medicine, University of Southern California School of Medicine, Los Angeles, CA

1996 - present, Member, City of Hope Comprehensive Cancer Center, Duarte, CA

1996 - present, Chief, Division of Clinical Cancer Genetics and Director, Cancer Screening & Prevention Program, City of Hope; and Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA

1996 - present, Staff Physician, Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA

1994 - 1996, Director, Familial Cancer Clinic, New England Medical Center, Boston, MA

1994 - 1996, Fellow in Clinical Genetics, Tufts Univ. School of Medicine, New England Medical Center, Boston, MA

1992 - 1996, Assistant Professor, Departments of Medicine and Obstetrics & Gynecology, Tufts University School of Medicine, Boston, MA

1988 - 1992, Instructor, Department of Medicine, Tufts University School of Medicine, Boston, MA

1987 - 1990, Fellow in Hematology-Oncology, Tufts University School of Medicine, Division of Hematology- Oncology, New England Medical Center Hospitals, Boston, MA

1986 - 1987, Research Fellow, Royal Postgraduate Medical School, Department of Haematology, Hammersmith Hospital, London, U.K.

Education and Training

1983 - 1986, University of Minnesota Hospitals and Clinics, Mpls, MN, Resident in Internal Medicine

1983, University of Minnesota Medical School, Mpls, MN, M.D., Medicine

1979, University of Minnesota, Mpls, MN,  B.S., Microbiology

This is an abbreviated document. Full CV available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 12/08.

Jeffrey Weitzel, M.D.
Honors and Awards

1992 - 1997, Clinical Investigator award, National Cancer Institute, NIH


1990 - 1992,
Clinical Oncology Career Development Award, American Cancer Society

1982, Alpha Omega Alpha Honor Medical Society

Professional Memberships

2005, Editorial Board, Journal of Clinical Oncology

1998, NCI Scientific Review Group Subcommittee G

1998, National Surgical Adjuvant Breast and Bowel Project

1998, Editorial Board, Breast Diseases: A Year Book Quarterly

1998 - present, American Society of Clinical Oncology

1997 - present, Southwest Oncology Group; Cancer Control and Breast Cancer Committees

1997 - present, Task Force on Cancer Genetics Education for the American Society of Clinical Oncology

1994 - present, American Society of Human Genetics

1993 - 1996, Medical Research Committee, American Cancer Society (Massachusetts Chapter)

1993 - 1996, Gynecologic Oncology Group, Applied Science and Tumor Biology Committee

1990, American Association for Cancer Research

Board Certifications

1996, Diplomate American Board of Medical Genetics; Subspecialty Clinical Genetics

1990, Diplomate Subspecialty Hematology

1989, Diplomate Subspecialty Medical Oncology

1986, Diplomate American Board of Internal Medicine

1984, Diplomate of the National Board of Medical Examiners

 Search

Go!
Advanced Search Options
News & Publications Search

 Contact Information

To request expert commentary on Breast Cancer, Genetics, Medical Oncology or Prevention/Screening, contact Media Relations.

To schedule an appointment, call 800-826-HOPE (4673) or complete our online form.

 Learn More

NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S.News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.